Ronald Melki

20.3k total citations · 8 hit papers
212 papers, 15.1k citations indexed

About

Ronald Melki is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Ronald Melki has authored 212 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Molecular Biology, 98 papers in Neurology and 65 papers in Physiology. Recurrent topics in Ronald Melki's work include Parkinson's Disease Mechanisms and Treatments (92 papers), Alzheimer's disease research and treatments (61 papers) and Prion Diseases and Protein Misfolding (58 papers). Ronald Melki is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (92 papers), Alzheimer's disease research and treatments (61 papers) and Prion Diseases and Protein Misfolding (58 papers). Ronald Melki collaborates with scholars based in France, United States and Switzerland. Ronald Melki's co-authors include Luc Bousset, Patrik Brundin, Laura Pieri, Ron R. Kopito, Karine Madiona, Veerle Baekelandt, Beat H. Meier, Dominique Pantaloni, Anja Böckmann and Wouter Peelaerts and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Ronald Melki

207 papers receiving 14.9k citations

Hit Papers

α-Synuclein strains cause distinct synucleinopathies afte... 2010 2026 2015 2020 2015 2014 2011 2013 2010 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
    2015 877 citations Wouter Peelaerts, Luc Bousset et al. profile →
  2. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
    2014 689 citations Luc Bousset, Ronald Melki et al. profile →
  3. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
    2011 670 citations Jennifer A. Steiner, Laura Pieri et al. profile →
  4. Structural and functional characterization of two alpha-synuclein strains
    2013 669 citations Luc Bousset, Laura Pieri et al. profile →
  5. Prion-like transmission of protein aggregates in neurodegenerative diseases
    2010 593 citations Patrik Brundin, Ronald Melki et al. profile →
  6. G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome
    2013 531 citations Luc Bousset, Laura Pieri et al. profile →
  7. Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes
    2021 232 citations Luc Bousset, Ronald Melki et al. profile →
  8. α‐synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities
    2019 224 citations Luc Bousset, Ronald Melki et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald Melki France 65 7.1k 7.1k 5.2k 3.4k 3.0k 212 15.1k
Hilal A. Lashuel Switzerland 82 10.2k 1.4× 7.4k 1.0× 8.6k 1.7× 4.0k 1.2× 1.8k 0.6× 227 20.9k
Luc Bousset France 48 3.6k 0.5× 5.3k 0.8× 3.7k 0.7× 2.4k 0.7× 2.3k 0.8× 109 9.3k
Ross Jakes United Kingdom 62 9.4k 1.3× 8.6k 1.2× 13.4k 2.6× 6.5k 1.9× 4.1k 1.4× 98 22.3k
Ludo Van Den Bosch Belgium 64 8.6k 1.2× 6.2k 0.9× 1.9k 0.4× 2.8k 0.8× 1.9k 0.6× 283 15.3k
R. Anthony Crowther United Kingdom 66 11.2k 1.6× 7.2k 1.0× 15.6k 3.0× 6.0k 1.7× 4.7k 1.6× 119 24.9k
Mathias Jucker Germany 73 9.8k 1.4× 2.8k 0.4× 13.8k 2.7× 4.5k 1.3× 7.0k 2.3× 179 22.5k
Erich E. Wanker Germany 59 12.5k 1.8× 3.3k 0.5× 3.6k 0.7× 8.1k 2.4× 719 0.2× 178 17.1k
Claudio Soto United States 79 13.4k 1.9× 2.9k 0.4× 8.4k 1.6× 1.8k 0.5× 4.4k 1.5× 239 21.5k
James Shorter United States 63 12.8k 1.8× 4.0k 0.6× 1.7k 0.3× 1.5k 0.4× 978 0.3× 161 15.9k
Nobuyuki Nukina Japan 62 9.1k 1.3× 3.4k 0.5× 4.3k 0.8× 4.9k 1.4× 1.2k 0.4× 206 14.6k

Countries citing papers authored by Ronald Melki

Since Specialization
Citations

This map shows the geographic impact of Ronald Melki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Melki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Melki more than expected).

Fields of papers citing papers by Ronald Melki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Melki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Melki. The network helps show where Ronald Melki may publish in the future.

Co-authorship network of co-authors of Ronald Melki

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Melki. A scholar is included among the top collaborators of Ronald Melki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Melki. Ronald Melki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angelova, Plamena R., Noemí Esteras, James R. Evans, et al.. (2025). α-synuclein fibrils per se but not α-synuclein seeded aggregation causes mitochondrial dysfunction and cell death in human neurons. Redox Biology. 86. 103817–103817.
2.
Stavropoulos, Athanasios, Christiane Volbracht, Louis De Muynck, et al.. (2025). In vivo validation of novel non-invasive PHP.eB AAVs as a potential therapeutic approach for alpha-synucleinopathies. Acta Neuropathologica Communications. 13(1). 207–207.
3.
Kordower, Jeffrey H., et al.. (2024). Alpha-synuclein aggregates are phosphatase resistant. Acta Neuropathologica Communications. 12(1). 84–84. 3 indexed citations
4.
Fenyi, Alexis, Sonia Lavisse, Sandra Doveró, et al.. (2023). Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: A pilot study in non-human primates. Neurobiology of Disease. 180. 106086–106086. 11 indexed citations
5.
Pan, Teng, et al.. (2023). Synapses do not facilitate prion-like transfer of alpha-synuclein: a quantitative study in reconstructed unidirectional neural networks. Cellular and Molecular Life Sciences. 80(10). 284–284. 4 indexed citations
6.
Perren, Anke Van der, Audrey Coens, Géraldine Gelders, et al.. (2022). Host oligodendrogliopathy and α-synuclein strains dictate disease severity in multiple system atrophy. Brain. 146(1). 237–251. 13 indexed citations
7.
Oliveira, Luís M. A., Thomas Gasser, Robert H. Edwards, et al.. (2021). Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease. npj Parkinson s Disease. 7(1). 65–65. 96 indexed citations
8.
Redeker, Virginie, et al.. (2020). Interaction of the chaperones alpha B-crystallin and CHIP with fibrillar alpha-synuclein: Effects on internalization by cells and identification of interacting interfaces. Biochemical and Biophysical Research Communications. 527(3). 760–769. 11 indexed citations
9.
Bousset, Luc, Mehdi Kabani, Carole Gardiennet, et al.. (2020). Prion Amyloid Polymorphs – The Tag Might Change It All. Frontiers in Molecular Biosciences. 7. 190–190. 2 indexed citations
10.
Guerrero-Ferreira, Ricardo, Nicholas M. I. Taylor, Ana‐Andreea Arteni, et al.. (2019). Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy. eLife. 8. 222 indexed citations
11.
Gribaudo, Simona, Luc Bousset, Alexis Fenyi, et al.. (2019). Propagation of α-Synuclein Strains within Human Reconstructed Neuronal Network. Stem Cell Reports. 12(2). 230–244. 95 indexed citations
12.
Rey, Nolwen L., Luc Bousset, Sonia George, et al.. (2019). α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb. Acta Neuropathologica Communications. 7(1). 221–221. 73 indexed citations
13.
Pepe, Anna, Nathalie Sassoon, Reiko Ueoka, et al.. (2019). Effect of tolytoxin on tunneling nanotube formation and function. Scientific Reports. 9(1). 5741–5741. 36 indexed citations
14.
Shrivastava, Amulya Nidhi, Virginie Redeker, Nicolas Fritz, et al.. (2015). α‐synuclein assemblies sequester neuronal α3‐Na + /K + ‐ ATP ase and impair Na + gradient. The EMBO Journal. 34(19). 2408–2423. 159 indexed citations
15.
Schütz, Anne K., Birgit Habenstein, Luc Bousset, et al.. (2013). Solid-state NMR sequential assignments of the amyloid core of full-length Sup35p. Biomolecular NMR Assignments. 8(2). 349–356. 12 indexed citations
16.
17.
Pucciarelli, Sandra, Sandra K. Parker, H. William Detrich, & Ronald Melki. (2006). Characterization of the cytoplasmic chaperonin containing TCP-1 from the Antarctic fish Notothenia coriiceps. Extremophiles. 10(6). 537–549. 17 indexed citations
18.
Bousset, Luc, et al.. (2002). Structure and assembly properties of the yeast prion Ure2p. Comptes Rendus Biologies. 325(1). 3–8. 4 indexed citations
19.
Melki, Ronald & Nicholas J. Cowan. (1994). Facilitated Folding of Actins and Tubulins Occurs via a Nucleotide-Dependent Interaction between Cytoplasmic Chaperonin and Distinctive Folding Intermediates. Molecular and Cellular Biology. 14(5). 2895–2904. 32 indexed citations
20.
Melki, Ronald & Marie France Carlier. (1993). Thermodynamics of tubulin polymerization into zinc sheets: Assembly is not regulated by GTP hydrolysis. Biochemistry. 32(13). 3405–3413. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hilal A. Lashuel Breakdown of academic impact, for papers by Luc Bousset Breakdown of academic impact, for papers by Ross Jakes Breakdown of academic impact, for papers by Ludo Van Den Bosch Breakdown of academic impact, for papers by R. Anthony Crowther Breakdown of academic impact, for papers by Mathias Jucker Breakdown of academic impact, for papers by Erich E. Wanker Breakdown of academic impact, for papers by Claudio Soto Breakdown of academic impact, for papers by James Shorter Breakdown of academic impact, for papers by Nobuyuki Nukina
Rankless by CCL
2026